News 21.11.2025 CUTISS has been awarded 2nd place at the 2025 edition of The Spark – Der Deutsche Digitalpreis, which recognizes outstanding deep-tech innovation across Germany, Austria, and Switzerland. The award ceremony in Munich brought together finalists from across a range of industries. CUTISS was recognized for its pioneering work in personalized regenerative...
Events, External events
Event date: 27.11.2025
Webinar: 11:30h - 13:00h
The Aryastha Biosolutions® Platform offers a comprehensive suite of advanced human-relevant preclinical models—including Patient-Derived Cells (PDCs), Tumor Organoids (PDTOs), Tumor Slice Cultures (PTSCs), and iTOX stem-cell–based toxicity models. These systems bridge the translational gap between in vitro research and clinical response, supporting Phase 0 trials to enhance...
News 13.11.2025 SCHLIEREN, Switzerland--(BUSINESS WIRE)--Virometix AG, a clinical-stage biotechnology company pioneering fully synthetic vaccines, today announced the completion of a $15 million financing round from existing shareholders. The funds will support continued clinical and development activities for V-212, Virometix’s lead serotype-independent pneumococcal vaccine candidate, currently in Phase I clinical evaluation. Proceeds from the financing...
News 12.11.2025 InSphero AG, the global market leader in 3D cell-based assays and organ-on-chip systems signed the definitive agreement to acquire DOPPL SA, a Lausanne-based innovator in the organoid space, including the Sun Bioscience Gri3D® technology. The acquisition strengthens InSphero’s position as the most comprehensive provider of advanced 3D in vitro models, combining scalable spheroid and organoid technologies with...
News 12.11.2025 ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), today announced the...